TLRY
Price
$0.69
Change
-$0.01 (-1.43%)
Updated
Jul 25 closing price
Capitalization
1.87B
One day until earnings call
TSMRF
Price
$23.74
Change
-$4.41 (-15.67%)
Updated
Jun 27 closing price
Capitalization
1.44B
Interact to see
Advertisement

TLRY vs TSMRF

Header iconTLRY vs TSMRF Comparison
Open Charts TLRY vs TSMRFBanner chart's image
Tilray Brands
Price$0.69
Change-$0.01 (-1.43%)
Volume$39.97M
Capitalization1.87B
Tsumura & Co
Price$23.74
Change-$4.41 (-15.67%)
Volume$100
Capitalization1.44B
TLRY vs TSMRF Comparison Chart in %
Loading...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSMRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TLRY vs. TSMRF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TLRY is a Hold and TSMRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (TLRY: $0.69 vs. TSMRF: $23.74)
Brand notoriety: TLRY: Notable vs. TSMRF: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: TLRY: 113% vs. TSMRF: 100%
Market capitalization -- TLRY: $1.87B vs. TSMRF: $1.44B
TLRY [@Pharmaceuticals: Other] is valued at $1.87B. TSMRF’s [@Pharmaceuticals: Other] market capitalization is $1.44B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TLRY’s FA Score shows that 0 FA rating(s) are green whileTSMRF’s FA Score has 2 green FA rating(s).

  • TLRY’s FA Score: 0 green, 5 red.
  • TSMRF’s FA Score: 2 green, 3 red.
According to our system of comparison, both TLRY and TSMRF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TLRY’s TA Score shows that 6 TA indicator(s) are bullish while TSMRF’s TA Score has 2 bullish TA indicator(s).

  • TLRY’s TA Score: 6 bullish, 4 bearish.
  • TSMRF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, TLRY is a better buy in the short-term than TSMRF.

Price Growth

TLRY (@Pharmaceuticals: Other) experienced а +10.82% price change this week, while TSMRF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Reported Earning Dates

TLRY is expected to report earnings on Jul 28, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLRY($1.87B) has a higher market cap than TSMRF($1.44B). TSMRF has higher P/E ratio than TLRY: TSMRF (12.64) vs TLRY (8.52). TSMRF YTD gains are higher at: -15.672 vs. TLRY (-48.233). TSMRF has higher annual earnings (EBITDA): 37B vs. TLRY (-1.23B). TSMRF has more cash in the bank: 93.7B vs. TLRY (260M). TLRY has less debt than TSMRF: TLRY (529M) vs TSMRF (79.7B). TSMRF has higher revenues than TLRY: TSMRF (138B) vs TLRY (700M).
TLRYTSMRFTLRY / TSMRF
Capitalization1.87B1.44B130%
EBITDA-1.23B37B-3%
Gain YTD-48.233-15.672308%
P/E Ratio8.5212.6467%
Revenue700M138B1%
Total Cash260M93.7B0%
Total Debt529M79.7B1%
FUNDAMENTALS RATINGS
TLRY vs TSMRF: Fundamental Ratings
TLRY
TSMRF
OUTLOOK RATING
1..100
2550
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
11
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9620
PRICE GROWTH RATING
1..100
4086
P/E GROWTH RATING
1..100
9497
SEASONALITY SCORE
1..100
9530

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TSMRF's Valuation (11) in the null industry is somewhat better than the same rating for TLRY (47) in the Biotechnology industry. This means that TSMRF’s stock grew somewhat faster than TLRY’s over the last 12 months.

TSMRF's Profit vs Risk Rating (100) in the null industry is in the same range as TLRY (100) in the Biotechnology industry. This means that TSMRF’s stock grew similarly to TLRY’s over the last 12 months.

TSMRF's SMR Rating (20) in the null industry is significantly better than the same rating for TLRY (96) in the Biotechnology industry. This means that TSMRF’s stock grew significantly faster than TLRY’s over the last 12 months.

TLRY's Price Growth Rating (40) in the Biotechnology industry is somewhat better than the same rating for TSMRF (86) in the null industry. This means that TLRY’s stock grew somewhat faster than TSMRF’s over the last 12 months.

TLRY's P/E Growth Rating (94) in the Biotechnology industry is in the same range as TSMRF (97) in the null industry. This means that TLRY’s stock grew similarly to TSMRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TLRYTSMRF
RSI
ODDS (%)
Bearish Trend 3 days ago
89%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
9%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
25%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
13%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
9%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
11%
View a ticker or compare two or three
Interact to see
Advertisement
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSMRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDERX12.290.10
+0.82%
PGIM Jennison Mid-Cap Growth R
PARNX60.640.39
+0.65%
Parnassus Mid Cap Growth Investor
RYSVX205.311.20
+0.59%
Rydex S&P SmallCap 600 Pure Value A
NWAVX14.380.06
+0.42%
Nationwide GQG US Quality Eq R6
ACSDX31.270.03
+0.10%
Invesco Comstock Y

TLRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TLRY has been loosely correlated with CGC. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if TLRY jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLRY
1D Price
Change %
TLRY100%
-2.03%
CGC - TLRY
62%
Loosely correlated
+2.70%
OGI - TLRY
58%
Loosely correlated
+1.32%
CRON - TLRY
58%
Loosely correlated
-0.97%
ACB - TLRY
53%
Loosely correlated
+0.62%
ELAN - TLRY
36%
Loosely correlated
+1.57%
More

TSMRF and

Correlation & Price change

A.I.dvisor tells us that TSMRF and ACB have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TSMRF and ACB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSMRF
1D Price
Change %
TSMRF100%
N/A
ACB - TSMRF
30%
Poorly correlated
+0.62%
HNSPF - TSMRF
29%
Poorly correlated
N/A
GEDSF - TSMRF
22%
Poorly correlated
N/A
TLRY - TSMRF
22%
Poorly correlated
-2.03%
CGC - TSMRF
21%
Poorly correlated
+2.70%
More